RALOXIFENE GxP Raloxifene hydrochloride 60 mg tablets, blister pack

Страна: Австралия

Язык: английский

Источник: Department of Health (Therapeutic Goods Administration)

Активный ингредиент:

raloxifene hydrochloride, Quantity: 60 mg

Доступна с:

MedTAS Pty Ltd

ИНН (Международная Имя):

Raloxifene hydrochloride

Фармацевтическая форма:

Tablet, film coated

состав:

Excipient Ingredients: microcrystalline cellulose; crospovidone; magnesium stearate; glycine; colloidal anhydrous silica; polysorbate 80; povidone; titanium dioxide; hypromellose; Carnauba Wax; macrogol 400

Администрация маршрут:

Oral

Штук в упаковке:

28 tablets

Тип рецепта:

(S4) Prescription Only Medicine

Терапевтические показания :

Raloxifene is indicated for the prevention and treatment of osteoporosis in post-menopausal women.,Raloxifene is indicated for the reduction in the risk of invasive breast cancer in postmenopausal women with osteoporosis.Raloxifene is indicated for the reduction in the risk of invasive breast cancer in postmenopausal women at high risk of invasive breast cancer.

Обзор продуктов:

Visual Identification: White to off-white, oval, biconvex, film coated tablets with 'C' on one side and '12' on other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Статус Авторизация:

Licence status A

Дата Авторизация:

2014-01-14